期刊文献+

右美托咪定用于减轻颅内动脉瘤患者麻醉诱导期血流动力学波动的临床价值 被引量:7

Clinical value of attenuating hemodynamic fluctuation in patients with cerebral aneurysm during anesthesia induction
原文传递
导出
摘要 目的探讨右美托咪定在颅内动脉瘤介入手术全身麻醉诱导期减少血流动力学波动中的应用。方法选择全身麻醉下行颅内动脉瘤介入手术的患者60例,采用随机数字表法分为低剂量芬太尼组、高剂量芬太尼组和低剂量芬太尼复合右美托咪定组(复合组),每组20例。麻醉诱导前,复合组经微量泵持续静脉注射右美托咪定,总量1恤g/kg,泵注时间10min;低剂量芬太尼组和高剂量芬太尼组注射等量0.9%氯化钠。麻醉诱导时,低剂量芬太尼组和复合组静脉注射芬太尼3μs/ks、高剂量芬太尼组静脉注射芬太尼5μs/ks,余用药相同。记录入手术室平静休息3min(T0)、气管内插管前即刻(T1)、插管后即刻(T2)、插管后3min(T3)的收缩压(SBP)、舒张压(DBP)、心率(HR)。将每例患者麻醉诱导期间(T0-T3)SBP、DBP、HR最大值与最小值之差定义为各参数的波动值:△SBP、ADBP、AHR。记录诱导期间麻黄碱、阿托品的使用情况。结果复合组ASBP、△DBP、AHR[(26.9±14.8)mmHg(1mmHg=0.133kPa)、(10.7±8.9)mmHg、(12.5±4.3)次/min]均低于低剂量芬太尼组[(40.4±15.6)mmHg、(20.3±9.4)mmHg、(30.1±15.0)次/min](P〈0.05),高剂量芬太尼组△SBP、△HR[(29.8±16.8)mmHg、(19.5±7.4)次/min]均低于低剂量芬太尼组(P〈0.05),复合组AHR低于高剂量芬太尼组(P〈0.05)。麻醉诱导期三组阿托品使用率比较差异无统计学意义(P=0.364),高剂量芬太尼组麻黄碱使用率高于低剂量芬太尼组[30%(6/20)比5%(1/20),P=0.03230结论麻醉诱导前应用1μg/kg右美托咪定,既能够良好抑制插管反应,又不会导致插管后血压严重下降,达到了稳定血流动力学的目标,特别适用于颅内动脉瘤患者的麻醉诱导。 Objective To investigate the application of dexmedetomidine attenuating hemodynamic fluctuation in patients with cerebral aneurysm during anesthesia induction. Methods Sixty patients undergoing elective interventional procedure with cerebral aneurysm were divided into low dose of fentanyl group (group LF), high dose of fentanyl group (group HF), and low dose of fentanyl and dexmedetomidine combination group (group FD) by random digits table method with 20 cases each. Before induction of anesthesia, the patients in group FD received dexmedetomidine 1μg/kg for 10 minutes, and the others received 0.9% sodium chloride with the same volume. During anesthesia induction, fentanyl 3 μg/kg in group LF and group FD, and fentanyl 5 μg/kg in group HF. Other anesthetics were equalized. Systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR) were monitored and recorded at 3 min utes after lying on table (To), before intubation (TI), immediately and 3 min utes after intubafion (T2,T3). The differences between the maximum and the minimum of SBP, DBP and HR were calculated in these time points as fluctuation values, named as A SBP, A DBP and A HR. Results A SBP, A DBP and A HR in group FD [(26.9 ± 14.8) mm Hg(1 mm Hg =0.133 kPa), (10.7 ±8.9) mm Hg, (12.5 ±4.3) times/mini were lower than those in group LF [ (40.4 ± 15.6) mm Hg, (20.3 ± 9.4) mm Hg, ( 30.1 ± 15.0) times/min ] (P 〈 0.05 ), as well as A SBP and A HR in group HF [ (29.8 ± 16.8 ) mra Hg, (19.5 ± 7.4) times/min ] were lower than those in group LF (P 〈 0.05). While A HR in group FD was lower than that in group HF (P 〈 0.05 ). The usage of atropin in three group had no statistical significance during anesthesia induction (P = 0.364) ,but more ephedrine was used in group HF than in group LF [30%(6/20) vs. 5%(1/20) ,P = 0.032]. Conclusion Dexmedetomidine 1μg/kg injected before anesthesia induction , which could prevent intubation reaction, blood pressure serious falling after intubation, and provide more stable hemodynamics, is particularly applicable for anesthesia induction in patients with cerebral aneurysm.
出处 《中国医师进修杂志》 2012年第12期1-3,共3页 Chinese Journal of Postgraduates of Medicine
关键词 颅内动脉瘤 麻醉 血流动力学 Intracranial aneurysm Anesthesia Hemodynamie
  • 相关文献

参考文献6

二级参考文献28

  • 1王庆,王珊娟,杭燕南.老年高血压患者围术期动态血压和动态心电图变化的临床研究[J].临床麻醉学杂志,2004,20(8):462-464. 被引量:36
  • 2陈惠荣,李军,刘永勤,吕浩,赵海涛.全麻复合硬膜外阻滞对上腹部手术病人应激反应的影响[J].临床麻醉学杂志,2005,21(2):95-96. 被引量:79
  • 3Mandel J E, Tanner J W, Lichtenstein G R, Metz D C, Katzka D A, Ginsberg G G,et al. A randomized, controlled, double-blind trial of patient-controlled sedation with propofol/remifentanil versus midazolam/fentanyl for colonoseopy[J]. Anesth Analg, 2008,106: 434-439.
  • 4Tan J A, Ho K M. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis [J]. Intensive Care Med, 2010,36 :926-939.
  • 5Mansour A, Fox C A, Akil H, Watson S J. Opioid-receptor mR NA expression in the rat CNS: anatomical and functional implications[J]. Trends Neurosci, 1995,18 : 22-29.
  • 6Cote A L,Zhang P,O'Sullivan J A,Jacobs V L,Clemis C R, Sakaguchi S, et al. Stimulation of the glucocorticoid induced TNF receptor family related receptor on CD8 T cells induces protective and high-avidity T cell responses to tumor-specific antigens[J]. J Immunol,2010 Nov 24. [Epub ahead of print].
  • 7Venn R M, Bryant A, Hall G M, Grounds R M. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post opera tive patients needing sedation in the intensive care unit[J]. Br J Anaesth, 2001, 86: 650-656.
  • 8Costello N L, Bragdon E E, Light K C, Sigurdsson A, Bunting S, Grewen K, et al. Temporomandibular disorder and optimism: relationships to ischemic pain sensitivity and interleukin-6[J]. Pain,2002,100(1-2) :99-110.
  • 9Wilkins B W, Hesse C, Charkoudian N, Nicholson W T, Svig gum H P, Moyer T P, et al. Autonomic cardiovascular control during a novel pharmacologic alternative to ganglionic blockade [J]. Clin Pharmacol Ther, 2008,83 :692-701.
  • 10Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: a review of clinical applications. Curr ()pin Anaesthesiol, 2008,21 : 457-461.

共引文献75

同被引文献61

  • 1Melake MS, Yamamoto M, Yoshida K, et al. A retrospective clin- ical and angiographic study of the coiling outcome of ruptured in- tracranial aneurysms [ J ]. J Clin Neurosci, 2010, 17 ( 3 ) : 328- 333.
  • 2Renowden SA, Benes V, Bradley M, et al. Detachable coil embo- lisation of ruptured intracranial aneurysms : a single center study, a decade experience[J]. Clin Neurol Neurosurg, 2009,111 (2): 179-188.
  • 3Winn HR, Jane JA Sr, Taylor J, et al. Prevalence of asymptomat- ic incidental aneurysms: review of 4568 arteriograms[ J]. J Neuro- surg, 2002,96( 1 ) :43-49.
  • 4Bederson JB, Awad IA, Wiebers DO, et al. Recommendations for the management of patients with unruptured intracranial aneu- 17sms: A Statement for hcahhcare professionals from the Stroke Council of the American Heart Association [ J ]. Stroke, 2000, 31 ( 11 ) :2742-2750.
  • 5Sen J, Belli A, Atbon H, et al. Triple-H therapy in the manage- ment of aneurysmal subarachnoid haemorrhage [ J ]. Lancet Neu- rol, 2003,2(10) :614-621.
  • 6Priebe HI. Aneurysmal subarachnoid haemorrhage and the anaes- thetist[ J]. Br J Anaesth, 2007,99 ( 1 ) : 102-118.
  • 7Cabrera LS, Santana AS, Robaina PE, et al. Paradoxical reaction to midazolam reversed with flumazenil [ J ]. J Emerg Trauma Shock, 2010,3(3) :307.
  • 8Weinbroum AA, Geller E. Flumazenil improves cognitive and neu- romotor emergence and attenuates shivering after halothane-, en- flurane- and isoflurane-based anesthesia [ J ]. Can J Anaesth, 2001,48 ( 10 ) :963-972.
  • 9Petroianu A, Alberti LR, de Lima DC, et al. Colonoscopic find- ings in asymptomatic people [ J ]. Arq Gastroenterol, 2009, 46(3) :173-178.
  • 10Golshevsky J, Cormack J. Laryngeal mask airway device during coiling of unruptured cerebral aneurysms [ J ]. J Clin Neurosci, 2009,16 ( 1 ) : 104-105.

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部